Morgan Stanley’s Genprex GNPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Hold |
0
| – | – | – | 8375 |
|
|
2026
Q1 | – | Hold |
0
| – | – | – | 8206 |
|
|
2025
Q4 | – | Sell |
-1
| Closed | -$141 | – | 8128 |
|
|
2025
Q3 | $162 | Hold |
1
| – | – | ﹤0.01% | 7621 |
|
|
2025
Q2 | $218 | Hold |
1
| – | – | ﹤0.01% | 7560 |
|
|
2025
Q1 | $235 | Sell |
1
-8
| -89% | -$4.44K | ﹤0.01% | 7458 |
|
|
2024
Q4 | $7.98K | Buy |
9
+8
| +800% | +$10.5K | ﹤0.01% | 6878 |
|
|
2024
Q3 | $569 | Hold |
1
| – | – | ﹤0.01% | 7288 |
|
|
2024
Q2 | $2.8K | Hold |
1
| – | – | ﹤0.01% | 6998 |
|
|
2024
Q1 | $4.46K | Hold |
1
| – | – | ﹤0.01% | 6921 |
|
|
2023
Q4 | $13.7K | Hold |
1
| – | – | ﹤0.01% | 6550 |
|
|
2023
Q3 | $17.7K | Hold |
1
| – | – | ﹤0.01% | 6524 |
|
|
2023
Q2 | $23.5K | Buy |
+1
| New | +$37.2K | ﹤0.01% | 6514 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6808 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6719 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6886 |
|
|
2022
Q2 | – | Sell |
-1
| Closed | -$70.4K | – | 6899 |
|
|
2022
Q1 | $76K | Sell |
1
-19
| -95% | -$1.85M | ﹤0.01% | 6481 |
|
|
2021
Q4 | $1.13M | Buy |
20
+18
| +900% | +$1.5M | ﹤0.01% | 4988 |
|
|
2021
Q3 | $257K | Sell |
2
-2
| -50% | -$259K | ﹤0.01% | 5866 |
|
|
2021
Q2 | $661K | Buy |
+4
| New | +$656K | ﹤0.01% | 5342 |
|
|
2021
Q1 | – | Sell |
-1
| Closed | -$220K | – | 6080 |
|
|
2020
Q4 | $129K | Buy |
+1
| New | +$155K | ﹤0.01% | 5802 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5644 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5639 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6106 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6687 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6675 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6680 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6628 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6638 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6742 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6588 |
|
Other funds holding GNPX
HF
EGM
MFA
TRCT
Morgan Stanley's GNPX Position: Q2 2026 in Review
Morgan Stanley held its Genprex (GNPX) position steady in Q2 2026 at 0 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #8375.
Morgan Stanley first reported a position in GNPX in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.13M in Q4 2021. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.
- Morgan Stanley held 0 shares of Genprex worth $3 as of Q2 2026.
- Morgan Stanley left its Genprex share count unchanged in Q2 2026.
- Genprex made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8375 holding.
- Morgan Stanley first reported a position in Genprex in Q4 2020 and has held it in 15 quarters since.
- Morgan Stanley's Genprex position peaked at $1.13M in Q4 2021.
- 17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.